Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Fibrinogen/fibrin

Citations 41-50 of 54 total displayed.

Past content (since May 2001):

Brief Rapid Communications
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Anetta Undas, Wojciech J. Sydor, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2003;107:17-20; published online before print as doi:10.1161/01.CIR.0000047062.03282.A3 [Abstract] [Full text]  

Articles
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Anetta Undas, Wojciech J. Sydor, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation published December 2, 2002, doi:10.1161/01.CIR.0000047062.03282.A3 [Abstract]  

Brief Rapid Communications
Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in Humans
Renu Virmani, Francesco Liistro, Goran Stankovic, Carlo Di Mario, Matteo Montorfano, Andrew Farb, Frank D. Kolodgie, and Antonio Colombo
Circulation 2002;106:2649-2651; published online before print as doi:10.1161/01.CIR.0000041632.02514.14 [Abstract] [Full text]  

Brief Rapid Communications
Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate-Eluting Polymer Stent System in Humans
Renu Virmani, Francesco Liistro, Goran Stankovic, Carlo Di Mario, Matteo Montorfano, Andrew Farb, Frank D. Kolodgie, and Antonio Colombo
Circulation published November 4, 2002, doi:10.1161/01.CIR.0000041632.02514.14 [Abstract]  

Clinical Investigations and Reports
Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease
Joseph D. Mills, Robert A.S. Ariëns, Michael W. Mansfield, and Peter J. Grant
Circulation 2002;106:1938-1942; published online before print as doi:10.1161/01.CIR.0000033221.73082.06 [Abstract] [Full text]  

Basic Science Reports
Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes: Studies in a New Experimental Model
Andrew Hamilton, Shao-Ling Huang, Drew Warnick, Adam Stein, Mark Rabbat, Taruna Madhav, Bonnie Kane, Ashwin Nagaraj, Melvin Klegerman, Robert MacDonald, and David McPherson
Circulation 2002;105:2772-2778; published online before print as doi:10.1161/01.CIR.0000017500.61563.80 [Abstract] [Full text]  

Correspondence
Activating Effects of GPIIb/IIIa Blockers: An Intrinsic Consequence of Ligand- Mimetic Properties Response
K. Peter, M. Schwarz, C. Bode, Andrew L. Frelinger, III, Mark I. Furman, Lori A. Krueger, Marc R. Barnard, and Alan D. Michelson
Circulation 2002;105:e180-181e, doi:10.1161/01.CIR.0000017280.72394.1F [Full text]  

Articles
Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes. Studies in a New Experimental Model
Andrew Hamilton, Shao-Ling Huang, Drew Warnick, Adam Stein, Mark Rabbat, Taruna Madhav, Bonnie Kane, Ashwin Nagaraj, Melvin Klegerman, Robert MacDonald, and David McPherson
Circulation published May 6, 2002, doi:10.1161/01.CIR.0000017500.61563.80 [Abstract]  

Clinical Investigations and Reports
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
S. Goya Wannamethee, Gordon D.O. Lowe, Peter H. Whincup, Ann Rumley, Mary Walker, and Lucy Lennon
Circulation 2002;105:1785-1790; published online before print as doi:10.1161/01.CIR.0000016346.14762.71 [Abstract] [Full text]  

Articles
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
S. Goya Wannamethee, Gordon D.O. Lowe, Peter H. Whincup, Ann Rumley, Mary Walker, and Lucy Lennon
Circulation published March 25, 2002, doi:10.1161/01.CIR.0000016346.14762.71 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6

* Subspecialty Collections Home

* Show  Fibrinogen/fibrin
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors